Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for Sleep Abnormalities in IBS
NCT04193501Phase 3Unknown
- Sponsor
- Sanjay Gandhi Postgraduate Institute of Medical Sciences
- Start
- Feb 2020
- Primary completion
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of melatonin in irritable bowel syndrome (IBS), sponsored by Sanjay Gandhi Postgraduate Institute of Medical Sciences. Status: unknown.
02
Drugs
melatonin
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT04193501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04193501.